Measurement of body surface energy leakage of defibrillation shock by an implantable cardioverter defibrillator

被引:3
|
作者
Niwano, S
Kojima, J
Inuo, K
Saito, J
Kashiwa, T
Suyama, M
Toyoshima, T
Aizawa, Y
Izumi, T
机构
[1] Kitasato Univ, Sch Med, Dept Internal Med, Sagamihara, Kanagawa 2288555, Japan
[2] Medtron Japan Co Ltd, Tachy Business Grp, Tokyo, Japan
[3] Medtron Japan Co Ltd, Res & Dev, Tokyo, Japan
[4] Niigata Univ, Sch Med, Dept Internal Med 1, Niigata, Japan
来源
关键词
defibrillation; electrical stimulation; electrical shock; tachyarrhythmias; antitachycardia device;
D O I
10.1046/j.1460-9592.2002.01212.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leakage of electrical current from the body surface during a defibrillation shock delivery by an ICD device was evaluated in 27 patients with life-threatening ventricular tachyarrhythmias. All patients underwent the implantation of the Medtronic jewel Plus ICD system, and the defibrillation shocks were delivered between the active can implanted in the left subclavicular region and the endocardial lead placed in the right ventricle. At the time of measurement of the effect of electrical energy delivery for defibrillation, the shocks were delivered in a biphasic form at the energy level of 20 or 30 J. During each delivery of the defibrillation shock, the electrical current to the body surface was measured through large skin electrodes (6.2 cm(2)) that were pasted at the following positions: (1) parallel position: the electrodes were placed at the left shoulder and the right low-chest, and the direction of the electrode vector was parallel to the direction of the defibrillation energy flow, and (2) cross position: the electrodes were placed at the right shoulder and the left low-chest, and the vector of the electrodes was roughly perpendicular to the direction of the energy flow. The energy leakages were measured in 80 defibrillation shocks. The peak leakage current during the shock delivery at energy of 30 J was 48 +/- 26 mA at the parallel position and 19 +/- 15 mA at the cross position (P = 0.0002). The energy leakage at a 30-J shock was 7.4 +/- 7.2 mJ at the parallel position and 1.4 +/- 2.3 mJ at the cross position (P = 0.0002). The actual maximum energy leakage was 105 mA, 29 mJ, and 106 V that appeared at the parallel position. The body surface leakage of the defibrillation energy of the ICD device was evaluated. The power of the energy leakage strongly depended on the angle between the alignment of the recording electrodes and the direction of the energy flow. The highest current leakage to the body surface reached a considerable level, but the energy leakage was small because of the short duration of the defibrillation shock.
引用
收藏
页码:1212 / 1218
页数:7
相关论文
共 50 条
  • [31] Cardiovascular responses to repetitive defibrillation during implantable cardioverter-defibrillator testing
    Gilbert, TB
    Gold, MR
    Shorofsky, SR
    Hasnain, JU
    Ferguson, MK
    Foster, AH
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2002, 16 (02) : 180 - 185
  • [32] Defibrillation testing of the subcutaneous implantable cardioverter-defibrillator at the time of generator replacement
    Schaller, Robert D.
    Hyman, Matthew
    Supple, Gregory E.
    Santangeli, Pasquale
    Riley, Michael P.
    Nazarian, Saman
    Arkles, Jeffrey
    Garcia, Fermin
    Lin, David
    Guandalini, Gustavo
    Kumareswaran, Ramanan
    Deo, Rajat
    Bode, Weeranun
    Markman, Timothy
    Epstein, Andrew
    Callans, David J.
    Dixit, Sanjay
    Brozoski, Joseph
    Marchlinski, Francis E.
    Frankel, David S.
    HEART RHYTHM, 2024, 21 (01) : 117 - 118
  • [33] Unexpectedly high defibrillation thresholds in an active can implantable cardioverter defibrillator system
    Rao, A
    Reynolds, DW
    Beckman, KJ
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (07): : 1168 - 1169
  • [34] Risk Factors For Defibrillation Testing Failure In Patients With Transvenous Implantable Cardioverter Defibrillator
    Nakano, Makoto
    Aizawa, Kentaro
    Hasebe, Yuhi
    Morosawa, Susumu
    Hayashi, Hideka
    Shimokawa, Hiroaki
    CIRCULATION, 2019, 140
  • [35] SUCCESS OF CHRONIC DEFIBRILLATION AND THE ROLE OF ANTIARRHYTHMIC DRUGS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    GUARNIERI, T
    LEVINE, JH
    VELTRI, EP
    GRIFFITH, LSC
    WATKINS, L
    JUANTEGUY, J
    MOWER, MM
    MIROWSKI, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (13): : 1061 - 1064
  • [36] Defibrillation threshold testing: Is it necessary during implantable cardioverter-defibrillator implantation?
    Liu, Qi-Ming
    Bai, Zhong-Le
    Liu, Zhen-Jiang
    Li, Xu-Ping
    Zhou, Sheng-Hua
    MEDICAL HYPOTHESES, 2009, 72 (02) : 147 - 149
  • [37] PATIENT WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND HIGH DEFIBRILLATION THRESHOLDS WITH LIMITED OPTIONS!
    Chaudry, Hayyan Asim
    Maskoun, Waddah
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3264 - 3264
  • [38] Optimizing the defibrillation vector with a right-sided implantable cardioverter-defibrillator
    Patton, K
    Reddy, VY
    HEART RHYTHM, 2004, 1 (06) : 756 - 756
  • [39] Phantom shock in a patient with an implantable cardioverter defibrillator: Case report
    Prudente, LA
    AMERICAN JOURNAL OF CRITICAL CARE, 2003, 12 (02) : 144 - 146
  • [40] Implantable cardioverter-defibrillator shock reduction: The new paradigm
    Bhakta, Deepak
    Foreman, Lynne D.
    HEART RHYTHM, 2011, 8 (12) : 1887 - 1888